These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23021156)

  • 41. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
    Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
    BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
    Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
    J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experiences of Support for Sexual Dysfunction in Men With Prostate Cancer: Findings From a U.K.-Wide Mixed Methods Study.
    Watson E; Wilding S; Matheson L; Brett J; McCaughan E; Downing A; Wright P; Cross W; Selby P; Butcher H; Glaser A; Gavin A; Wagland R
    J Sex Med; 2021 Mar; 18(3):515-525. PubMed ID: 33642238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.
    Chan JM; Van Blarigan EL; Langlais CS; Zhao S; Ramsdill JW; Daniel K; Macaire G; Wang E; Paich K; Kessler ER; Beer TM; Lyons KS; Broering JM; Carroll PR; Kenfield SA; Winters-Stone KM
    J Med Internet Res; 2020 Dec; 22(12):e19238. PubMed ID: 33382378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decision-making processes among men with low-risk prostate cancer: A survey study.
    Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
    Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.
    Broughman JR; Basak R; Nielsen ME; Reeve BB; Usinger DS; Spearman KC; Godley PA; Chen RC
    J Natl Cancer Inst; 2018 Apr; 110(4):420-425. PubMed ID: 29045679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
    Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
    Trials; 2015 May; 16():231. PubMed ID: 26012700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.
    Beydoun HA; Mohan R; Beydoun MA; Davis J; Lance R; Schellhammer P
    BJU Int; 2010 Aug; 106(3):334-41. PubMed ID: 20151969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
    Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
    Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
    Belkora J; Chan JM; Cooperberg MR; Neuhaus J; Stupar L; Weinberg T; Broering JM; Tenggara I; Cowan JE; Rosenfeld S; Kenfield SA; Van Blarigan EL; Simko JP; Witte J; Carroll PR
    Cancer Med; 2020 Jan; 9(1):125-132. PubMed ID: 31714037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.
    Lee DJ; Barocas DA; Zhao Z; Huang LC; Resnick MJ; Koyoma T; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):116-126. PubMed ID: 30102188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
    Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
    J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.
    Schofield P; Gough K; Hyatt A; White A; Frydenberg M; Chambers S; Gordon LG; Gardiner R; Murphy DG; Cavedon L; Richards N; Murphy B; Quinn S; Juraskova I
    Trials; 2021 Jan; 22(1):49. PubMed ID: 33430950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
    Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
    Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices.
    van Stam MA; Aaronson NK; Bosch JLHR; Kieffer JM; van der Voort van Zyp JRN; Tillier CN; Horenblas S; van der Poel HG
    Eur Urol Oncol; 2020 Feb; 3(1):21-31. PubMed ID: 31411965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study.
    Paudel R; Ferrante S; Woodford J; Maitland C; Stockall E; Maatman T; Lane GI; Berry DL; Sales AE; Montie JE;
    Implement Sci Commun; 2021 Mar; 2(1):27. PubMed ID: 33676583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.